Real-time enrollment status for this primary immunodeficiency (pid) clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:14 AM UTC
| NCT Number | NCT04528355 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiency (PID) |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Paul Szabolcs |
| Last Updated on CT.gov | January 13, 2026 (Jan 13, 2026) |
As of July 19, 2026: Clinical trial NCT04528355 is currently recruiting participants. This clinical trial study for primary immunodeficiency (pid) is actively seeking new participants at 1 location across the United States. The study is sponsored by Paul Szabolcs. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04528355 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04528355 was last updated Jan 13, 2026 (January 13, 2026). HelloStudys verifies this status automatically.